Physician profile
John J Faillace
NPI 1952344269
$211,593.11
in general payments reported to CMS, 2019-2025
20 companies · $28K in 2025
The $28K reported for 2025 was more than what 97% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $10K · 2021: $28K · 2022: $40K · 2023: $41K · 2024: $33K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $49K · Honoraria: $17K · Travel and Lodging: $16K · Consulting Fee: $12K · Food and Beverage: $7,691 · Education: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $49,037.90 |
| Honoraria | $16,800.00 |
| Travel and Lodging | $15,617.11 |
| Consulting Fee | $12,116.75 |
| Food and Beverage | $7,690.66 |
| Education | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $98,234.72 | 2019-2025 | Xmcp |
| Biopro, INC. | $80,791.15 | 2019-2025 | Mod Thumb, Mod Thumb, Clover Staple |
| Tyber Medical, LLC | $23,861.51 | 2019-2023 | Tyber Medical Anatomical Plating System |
| Trimed, INC. | $4,303.25 | 2020-2024 | |
| Axogen | $1,207.17 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Linvatec Corporation | $605.82 | 2023 | Biobrace 23mm |
| Ensemble Orthopedics, INC | $496.80 | 2022-2024 | Ensemble Cmc |
| Stryker Corporation | $401.87 | 2021-2023 | Mako |
| Hologic INC | $300.00 | 2022 | |
| Acumed LLC | $269.51 | 2022-2023 | Acumed |
| Depuy Synthes Sales INC. | $242.57 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $173.38 | 2020-2021 | |
| Captiox LLC | $150.00 | 2025 | Captiox Ulnar Shortening Implant, Captiox Cmc Spacer |
| Integra Lifesciences Corporation | $141.11 | 2022 | |
| Sanara Medtech INC. | $138.85 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $77.78 | 2019 | |
| Acera Surgical, INC. | $75.22 | 2022-2024 | Restrata Wound Matrix |
| Carbofix Orthopedics INC | $45.10 | 2025 | |
| Medinc of Texas | $38.88 | 2024 | |
| Polynovo North America LLC | $38.42 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,521,537.78 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Faillace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.